HLB bioStep Co.,Ltd. (KOSDAQ: 278650)
South Korea
· Delayed Price · Currency is KRW 2,005.00
-35.00 (-1.72%)
Dec 20, 2024, 9:00 AM KST
HLB bioStep Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Operating Revenue | 56,755 | 52,814 | 86,277 | 64,403 | 58,520 | 46,040 | Upgrade
|
| Other Revenue | - | - | - | 0 | - | - | Upgrade
|
| Revenue | 56,755 | 52,814 | 86,277 | 64,403 | 58,520 | 46,040 | Upgrade
|
| Revenue Growth (YoY) | -9.67% | -38.79% | 33.96% | 10.05% | 27.11% | 23.64% | Upgrade
|
| Cost of Revenue | 16,910 | 16,791 | 32,343 | 23,147 | 15,819 | 12,927 | Upgrade
|
| Gross Profit | 39,845 | 36,023 | 53,934 | 41,256 | 42,701 | 33,113 | Upgrade
|
| Selling, General & Admin | 41,738 | 32,365 | 40,986 | 26,527 | 29,515 | 23,170 | Upgrade
|
| Research & Development | 978.51 | 811.99 | 978.14 | 1,165 | 1,085 | 1,012 | Upgrade
|
| Other Operating Expenses | 795.19 | 712.99 | 709.09 | 696.32 | 500.65 | 309.66 | Upgrade
|
| Operating Expenses | 48,125 | 37,209 | 48,625 | 32,249 | 35,662 | 27,240 | Upgrade
|
| Operating Income | -8,280 | -1,186 | 5,309 | 9,007 | 7,040 | 5,873 | Upgrade
|
| Interest Expense | -1,259 | -3,471 | -4,246 | -184.7 | -202.22 | -651.03 | Upgrade
|
| Interest & Investment Income | 2,062 | 1,469 | 1,401 | 85 | 205.4 | 166.79 | Upgrade
|
| Earnings From Equity Investments | -376.31 | -488.74 | -1,659 | 3,608 | -56.87 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.39 | 32.3 | 13.81 | 9.9 | -6.45 | 1.44 | Upgrade
|
| Other Non Operating Income (Expenses) | 526.31 | 561.71 | -2,767 | 775.48 | 235.87 | -297.58 | Upgrade
|
| EBT Excluding Unusual Items | -7,328 | -3,083 | -1,947 | 13,300 | 7,215 | 5,092 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,833 | 3,418 | 534.22 | -440.56 | 2,259 | 654.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | 128.24 | -9.47 | -23.37 | -33.11 | -3.31 | -371.44 | Upgrade
|
| Asset Writedown | - | - | -907.99 | - | - | - | Upgrade
|
| Pretax Income | -5,368 | 325.66 | -2,345 | 12,827 | 9,471 | 5,375 | Upgrade
|
| Income Tax Expense | 226.17 | 379.9 | -1,462 | 1,295 | 881.82 | 821.13 | Upgrade
|
| Earnings From Continuing Operations | -5,594 | -54.24 | -882.73 | 11,532 | 8,589 | 4,554 | Upgrade
|
| Net Income to Company | -5,594 | -54.24 | -882.73 | 11,532 | 8,589 | 4,554 | Upgrade
|
| Minority Interest in Earnings | 655 | -109.81 | -125.27 | -501.4 | -287.6 | -358.55 | Upgrade
|
| Net Income | -4,939 | -164.04 | -1,008 | 11,031 | 8,302 | 4,195 | Upgrade
|
| Net Income to Common | -4,939 | -164.04 | -1,008 | 11,031 | 8,302 | 4,195 | Upgrade
|
| Net Income Growth | - | - | - | 32.87% | 97.88% | 18.03% | Upgrade
|
| Shares Outstanding (Basic) | 83 | 77 | 70 | 68 | 67 | 58 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 77 | 70 | 70 | 69 | 61 | Upgrade
|
| Shares Change (YoY) | 7.43% | 9.59% | 0.02% | 1.35% | 13.51% | 2.32% | Upgrade
|
| EPS (Basic) | -59.79 | -2.14 | -14.40 | 161.87 | 123.76 | 72.20 | Upgrade
|
| EPS (Diluted) | -59.79 | -2.14 | -14.40 | 158.00 | 120.22 | 69.00 | Upgrade
|
| EPS Growth | - | - | - | 31.42% | 74.24% | 12.83% | Upgrade
|
| Free Cash Flow | -20,935 | 1,189 | 1,587 | -11,135 | 7,517 | -364.27 | Upgrade
|
| Free Cash Flow Per Share | -253.46 | 15.51 | 22.67 | -159.09 | 108.85 | -5.99 | Upgrade
|
| Gross Margin | 70.20% | 68.21% | 62.51% | 64.06% | 72.97% | 71.92% | Upgrade
|
| Operating Margin | -14.59% | -2.25% | 6.15% | 13.99% | 12.03% | 12.76% | Upgrade
|
| Profit Margin | -8.70% | -0.31% | -1.17% | 17.13% | 14.19% | 9.11% | Upgrade
|
| Free Cash Flow Margin | -36.89% | 2.25% | 1.84% | -17.29% | 12.84% | -0.79% | Upgrade
|
| EBITDA | -3,867 | 2,290 | 9,412 | 12,033 | 9,095 | 7,303 | Upgrade
|
| EBITDA Margin | -6.81% | 4.33% | 10.91% | 18.68% | 15.54% | 15.86% | Upgrade
|
| D&A For EBITDA | 4,413 | 3,476 | 4,103 | 3,026 | 2,056 | 1,430 | Upgrade
|
| EBIT | -8,280 | -1,186 | 5,309 | 9,007 | 7,040 | 5,873 | Upgrade
|
| EBIT Margin | -14.59% | -2.25% | 6.15% | 13.99% | 12.03% | 12.76% | Upgrade
|
| Effective Tax Rate | - | 116.66% | - | 10.09% | 9.31% | 15.28% | Upgrade
|
| Advertising Expenses | - | 152.13 | 340.63 | 256.01 | 126.79 | 70.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.